Skip to main content
. 2020 May 5;69(9):1881–1890. doi: 10.1007/s00262-020-02595-8

Table 3.

Univariate and multivariate Cox proportional hazard regression analyses of 18 biomarkers

Gene Univariate Multivariate (18 markers)
HR (95% CI) p value HR (95% CI) p value
ARNTL2 1.35(1.19–1.53) 4.45E−06 1.01(0.83–1.24) 0.89
PLA2G4F 0.83(0.77–0.90) 7.82E−06 0.94(0.84–1.04) 0.24
CYP17A1 0.91(0.86–0.95) 5.49E−05 0.94(0.89–1.00) 3.54E−02
LOXL2 1.31(1.15–1.51) 8.39E−05 1.13(0.94–1.35) 0.20
HMMR 1.32(1.14–1.53) 2.13E−04 1.03(0.83–1.28) 0.80
NKX2-5 1.09(1.04–1.15) 3.23E−04 1.04(0.98–1.10) 0.21
GJB2 1.20(1.08–1.32) 3.86E−04 1.02(0.90–1.17) 0.73
DSG3 1.10(1.04–1.16) 4.09E−04 1.00(0.95–1.07) 0.88
SIX1 0.84(0.77–0.93) 4.24E−04 0.86(0.76–0.98) 2.38E−02
MC4R 0.91(0.86–0.96) 8.00E−04 0.95(0.89–1.00) 6.65E−02
TRPA1 1.13(1.05–1.21) 9.70E−04 1.00(0.91–1.10) 0.94
RAET1L 1.07(1.03–1.12) 1.12E−03 1.00(0.95–1.06) 0.87
KLF4 1.28(1.10–1.49) 1.47E−03 1.15(0.96–1.39) 0.13
HSF2BP 1.30(1.11–1.53) 1.48E−03 1.04(0.88–1.25) 0.63
GRIP1 1.21(1.08–1.37) 1.69E−03 1.19(1.05–1.35) 8.53E−03
PTPRN 1.10(1.03–1.16) 1.69E−03 1.02(0.94–1.09) 0.66
MAPK4 1.10(1.04–1.17) 2.01E−03 1.05(0.99–1.12) 0.11
PLOD2 1.23(1.08–1.40) 2.14E−03 1.06(0.87–1.29) 0.57